financetom
ATRI
financetom
/
Healthcare
/
ATRI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Atrion CorporationATRI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally.

The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery.

The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults.

It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications.

The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors.

Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Latest News >
G Mining Ventures Draws Remaining US$33 Million on Term Loan; Move Comes Day After Company Announced Merger
G Mining Ventures Draws Remaining US$33 Million on Term Loan; Move Comes Day After Company Announced Merger
Apr 23, 2024
07:39 AM EDT, 04/23/2024 (MT Newswires) -- G Mining Ventures ( GMINF ) , a day after it lost 10% on announcing that it would merge with Reunion Gold ( RGDFF ) , said on Tuesday that it has drawn the remaining approximately US$33 million on its US$75 million senior secured term loan with an affiliate of Franco-Nevada Corporation (...
Solaris Resources Reports First Results From 2024 Drill Program at Warintza Project in Ecuador
Solaris Resources Reports First Results From 2024 Drill Program at Warintza Project in Ecuador
Apr 23, 2024
07:41 AM EDT, 04/23/2024 (MT Newswires) -- Solaris Resources ( SLSR ) reported Tuesday the first results from its 2024 drilling program at the Warintza project in Ecuador. Highlights include 150 meters of 0.67% copper equivalent within 384 meters of 0.51% copper equivalent and 284 meters of 0.53% copper equivalent. The company said exploration drilling is underway at the Patrimonio...
Top Premarket Decliners
Top Premarket Decliners
Apr 23, 2024
07:39 AM EDT, 04/23/2024 (MT Newswires) -- Abeona Therapeutics ( ABEO ) shares slumped 48% Tuesday premarket after the company said that it plans to resubmit its biologic license application for pz-cel after the US Food and Drug Administration has asked for more data. T2 Biosystems ( TTOO ) shares fell 17% following a 6.8% rise in the previous session....
Kimberly-Clark's Q1 Adjusted EPS Rise, Revenue Declines; Raises 2024 Guidance; Shares Up Pre-Bell
Kimberly-Clark's Q1 Adjusted EPS Rise, Revenue Declines; Raises 2024 Guidance; Shares Up Pre-Bell
Apr 23, 2024
07:41 AM EDT, 04/23/2024 (MT Newswires) -- Kimberly-Clark ( KMB ) reported Q1 adjusted earnings Tuesday of $2.01 per diluted share, compared with $1.67 a year earlier. Analysts surveyed by Capital IQ expected $1.64. Revenue for the quarter ended March 31 was $5.15 billion, compared with $5.20 billion a year earlier. Analysts surveyed by Capital IQ expected $5.09 billion. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved